NRIM
NORTHRIM BANCORP INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- B Jan 30 1 insider buy $30.0K at $23.24
- R Apr 22 Northrim BanCorp reported Q1 2026 earnings of $0.61 per diluted shar…
- S Jul 31 to Aug 3 2 days of insider sells: $463.3K by 2 insiders, avg $26.49
- S Aug 28 to Aug 31 2 days of insider sells: $121.1K by 2 insiders, avg $25.81
- B Sep 8 1 insider buy $31.4K at $26.20
- A Sep 8 Hovde Group initiates
- X Sep 30 Short interest jumps 34.6% to 1.23M
- E Oct 22 M&A: Northrim BanCorp, Inc. and PBCO Financial Corporation Anno…
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders bought $61.4K at an average $24.67. 4 insiders sold $584.4K.
- InstitutionsBULLISH
Q2 2026: 17 added (0 new), 8 trimmed or exited.
- AnalystsBULLISH
6 of 8 rate it Buy or better. Every target is above the price.
- EstimatesRISING
Current-quarter EPS estimate $0.640 → $0.667 over 90 days. 1 up, 1 down in 30 days.
- Short sellersSTEADY
Short interest −1.1% to 1.22M shares. 10.3 days to cover, ≈5.5% of shares.
- TrendDOWNTREND
5% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| GOLDMAN SACHS GROUP INC | ADD | $7.9M |
| MORGAN STANLEY | TRIM | $4.0M |
| CITADEL ADVISORS LLC | DOUBLED | $3.4M |
| Empowered Funds, LLC | ADD | $2.5M |
| PANAGORA ASSET MANAGEMENT INC | ADD | $2.3M |
| UBS Group AG | DOUBLED | $2.0M |
| LAZARD ASSET MANAGEMENT LLC | DOUBLED | $1.9M |
| Nuveen, LLC | ADD | $1.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
8 analystsPrice is below the lowest target. Median implies +18%.Targets as of Oct 28, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 19, 2026 | Keefe, Bruyette & Woods MAINTAIN | Market Perform |
| Sep 8, 2026 | Hovde Group INITIATE | Outperform |
| Jul 1, 2026 | Keefe, Bruyette & Woods INITIATE | Market Perform |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 8, 2026 | Thomas Linda C Director | BUY | $31.4K |
| Aug 31, 2026 | DRABEK ANTHONY Director | SELL | $30.6K |
| Aug 28, 2026 | Ballard Jed W EVP, CFO | SELL | $87.9K |
| Aug 28, 2026 | Ballard Jed W EVP, CFO | SELL | $2.6K |
| Aug 3, 2026 | EDWARDS MARK DOUGLAS EVP, CCO of Northrim Bank | SELL | $54.0K |
| Jul 31, 2026 | EDWARDS MARK DOUGLAS EVP, CCO of Northrim Bank | SELL | $52.7K |
| Jul 31, 2026 | CRIQUI JASON ALEXANDER EVP, CBO of Northrim Bank | SELL | $13.3K |
| Jul 31, 2026 | CRIQUI JASON ALEXANDER EVP, CBO of Northrim Bank | SELL | $13.2K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.67 | $0.66–$0.67 | +3.1% | $55.4M |
| Next Q | $0.60 | $0.59–$0.61 | +0.3% | $65.0M |
| Current FY | $2.52 | $2.47–$2.55 | -4.3% | $216.6M |
| Next FY | $2.70 | $2.67–$2.74 | -2.2% | $271.4M |
Short side
FINRA· Oct 15, 2026SecBot reports
12 filings · 3 press releases · 4 bullish · 2 bearish · 6 neutral- NEUTRAL 8-KOct 22, 2026
Northrim BanCorp shareholders voted overwhelmingly (98.5% of votes cast) to approve the issuance…
Shareholder approval removes a key condition precedent. The next catalyst is regulatory clearance from banking authorities. Monitor for any updates on the regulatory approval timeline or conditions…
- NEUTRAL PRESS RELEASEOct 22, 2026
Northrim BanCorp and PBCO Financial Corporation have received all required shareholder approvals…
Monitor regulatory approval timeline and any updates on the Specialty Finance portfolio's credit quality, as the prior quarter's impairment signals elevated risk in that segment.
- BEARISH PRESS-RELEASEOct 15, 2026
Northrim BanCorp reported Q3 2026 adjusted EPS of $0.60, a 14.3% miss vs consensus of $0.70…
Monitor resolution of the $20M impaired Specialty Finance loan over the next 2-3 quarters; the $8.8M impairment suggests potential for further charge-offs. Watch for Q4 2026 earnings for updates on…
- BEARISH 8-KOct 15, 2026
Northrim BanCorp reported Q3 2026 adjusted EPS of $0.60, a 10% miss vs consensus of $0.67, and net…
The $8.8M impairment on a single $20M Specialty Finance loan is the key risk event — watch for further deterioration in that segment and any spillover to the Community Banking portfolio. The strong…
All NRIM filing & press-release reports (15)
- 8-K reportOct 22, 2026
- PRESS-RELEASE reportOct 22, 2026
- PRESS-RELEASE reportOct 15, 2026
- 8-K reportOct 15, 2026
- EFFECT reportSep 18, 2026
- S-4/A reportSep 15, 2026
- CLUSTER reportAug 31, 2026
- PRESS-RELEASE reportAug 28, 2026
- 8-K reportJul 23, 2026
- PRESS-RELEASE reportJul 22, 2026
- PRESS-RELEASE reportJul 22, 2026
- 8-K reportApr 22, 2026
- PRESS-RELEASE reportApr 22, 2026
- DEFA14A reportApr 14, 2026
- EFFECT reportMar 12, 2026